×

Formulations for reducing neuronal degeneration

  • US 8,173,618 B2
  • Filed: 07/23/2004
  • Issued: 05/08/2012
  • Est. Priority Date: 07/25/2003
  • Status: Active Grant
First Claim
Patent Images

1. A composition comprising 3-deaza-adenosine (DZA), N-acetyl-L-cysteine (NAC), and S-adenosylmethionine (SAM) in combination or in individual dosage forms, wherein a unit dose of the composition reduces a level of reactive oxygen species (ROS) in an in vitro neural cell culture.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×